Liabilities and Equity in USD of LENNAR CORP /NEW/ from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
LENNAR CORP /NEW/ quarterly Liabilities and Equity history and change rate from Q3 2010 to Q3 2025.
  • LENNAR CORP /NEW/ Liabilities and Equity for the quarter ending 31 Aug 2025 was $34.9B, a 12.2% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

LENNAR CORP /NEW/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $34.9B -$4.86B -12.2% 31 Aug 2025 10-Q 03 Oct 2025
Q2 2025 $34.4B -$4.29B -11.1% 31 May 2025 10-Q 01 Jul 2025
Q1 2025 $35B -$3.97B -10.2% 28 Feb 2025 10-Q 04 Apr 2025
Q4 2024 $41.3B +$2.08B +5.3% 30 Nov 2024 10-Q 03 Oct 2025
Q3 2024 $39.7B +$2.3B +6.15% 31 Aug 2024 10-Q 02 Oct 2024
Q2 2024 $38.7B +$1.81B +4.91% 31 May 2024 10-Q 28 Jun 2024
Q1 2024 $39B +$2.38B +6.5% 29 Feb 2024 10-Q 29 Mar 2024
Q4 2023 $39.2B +$1.25B +3.29% 30 Nov 2023 10-K 23 Jan 2025
Q3 2023 $37.4B +$2.1B +5.94% 31 Aug 2023 10-Q 29 Sep 2023
Q2 2023 $36.9B +$2.55B +7.44% 31 May 2023 10-Q 30 Jun 2023
Q1 2023 $36.6B +$3.94B +12.1% 28 Feb 2023 10-Q 04 Apr 2023
Q4 2022 $38B +$4.78B +14.4% 30 Nov 2022 10-K 26 Jan 2024
Q3 2022 $35.3B +$2.6B +7.93% 31 Aug 2022 10-Q 04 Oct 2022
Q2 2022 $34.3B +$3.08B +9.87% 31 May 2022 10-Q 01 Jul 2022
Q1 2022 $32.6B +$2.08B +6.82% 28 Feb 2022 10-Q 01 Apr 2022
Q4 2021 $33.2B +$3.27B +10.9% 30 Nov 2021 10-K 26 Jan 2023
Q3 2021 $32.7B +$3.43B +11.7% 31 Aug 2021 10-Q 01 Oct 2021
Q2 2021 $31.2B +$1.91B +6.53% 31 May 2021 10-Q 02 Jul 2021
Q1 2021 $30.6B +$1.38B +4.72% 28 Feb 2021 10-Q 01 Apr 2021
Q4 2020 $29.9B +$576M +1.96% 30 Nov 2020 10-K 28 Jan 2022
Q3 2020 $29.3B -$144M -0.49% 31 Aug 2020 10-Q 01 Oct 2020
Q2 2020 $29.3B -$274M -0.93% 31 May 2020 10-Q 06 Jul 2020
Q1 2020 $29.2B +$424M +1.47% 29 Feb 2020 10-Q 07 Apr 2020
Q4 2019 $29.4B +$793M +2.78% 30 Nov 2019 10-K 22 Jan 2021
Q3 2019 $29.5B +$1.17B +4.14% 31 Aug 2019 10-Q 08 Oct 2019
Q2 2019 $29.6B +$1.23B +4.35% 31 May 2019 10-Q 03 Jul 2019
Q1 2019 $28.7B +$806M +2.88% 28 Feb 2019 10-Q 08 Apr 2019
Q4 2018 $28.6B +$9.82B +52.4% 30 Nov 2018 10-K 27 Jan 2020
Q3 2018 $28.3B +$11.4B +67% 31 Aug 2018 10-Q 09 Oct 2018
Q2 2018 $28.4B +$11.6B +69.2% 31 May 2018 10-Q 06 Jul 2018
Q1 2018 $27.9B +$11.7B +72.2% 28 Feb 2018 10-Q 09 Apr 2018
Q4 2017 $18.7B +$3.38B +22% 30 Nov 2017 10-K 28 Jan 2019
Q3 2017 $16.9B +$1.94B +12.9% 31 Aug 2017 10-Q 10 Oct 2017
Q2 2017 $16.8B +$1.91B +12.8% 31 May 2017 10-Q 30 Jun 2017
Q1 2017 $16.2B +$2.03B +14.3% 28 Feb 2017 10-Q 10 Apr 2017
Q4 2016 $15.4B +$942M +6.54% 30 Nov 2016 10-K 25 Jan 2018
Q3 2016 $15B +$829M +5.85% 31 Aug 2016 10-Q 04 Oct 2016
Q2 2016 $14.8B +$952M +6.85% 31 May 2016 10-Q 01 Jul 2016
Q1 2016 $14.2B +$1.07B +8.19% 29 Feb 2016 10-Q 06 Apr 2016
Q4 2015 $14.4B +$1.5B +11.6% 30 Nov 2015 10-K 20 Jan 2017
Q3 2015 $14.2B +$1.88B +15.3% 31 Aug 2015 10-Q 09 Oct 2015
Q2 2015 $13.9B +$1.9B +15.8% 31 May 2015 10-Q 02 Jul 2015
Q1 2015 $13.1B +$1.59B +13.8% 28 Feb 2015 10-Q 03 Apr 2015
Q4 2014 $12.9B +$1.65B +14.6% 30 Nov 2014 10-K 22 Jan 2016
Q3 2014 $12.3B +$1.27B +11.6% 31 Aug 2014 10-Q 03 Oct 2014
Q2 2014 $12B +$1.5B +14.3% 31 May 2014 10-Q 03 Jul 2014
Q1 2014 $11.5B +$1.09B +10.5% 28 Feb 2014 10-Q 09 Apr 2014
Q4 2013 $11.3B +$911M +8.79% 30 Nov 2013 8-K 29 Oct 2015
Q3 2013 $11B +$1.3B +13.3% 31 Aug 2013 10-Q 10 Oct 2013
Q2 2013 $10.5B +$1.14B +12.2% 31 May 2013 10-Q 10 Jul 2013
Q1 2013 $10.4B +$1.56B +17.6% 28 Feb 2013 10-Q/A 01 Aug 2013
Q4 2012 $10.4B +$1.21B +13.2% 30 Nov 2012 10-K 28 Jan 2014
Q3 2012 $9.72B +$994M +11.4% 31 Aug 2012 10-Q 10 Oct 2012
Q2 2012 $9.35B +$652M +7.5% 31 May 2012 10-Q 10 Jul 2012
Q1 2012 $8.87B +$287M +3.35% 29 Feb 2012 10-Q 09 Apr 2012
Q4 2011 $9.15B +$367M +4.17% 30 Nov 2011 10-K/A 01 Aug 2013
Q3 2011 $8.72B +$444M +5.36% 31 Aug 2011 10-Q 11 Oct 2011
Q2 2011 $8.7B 31 May 2011 10-Q 11 Jul 2011
Q1 2011 $8.58B 28 Feb 2011 10-Q 11 Apr 2011
Q4 2010 $8.79B 30 Nov 2010 10-K 30 Jan 2012
Q3 2010 $8.28B 31 Aug 2010 10-Q 08 Oct 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.